Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carol A Feghali-Bostwick

Showing results (1-10 of 80) with videos related to

Pageof 8
Sort By:
Current Rheumatology Reports|March 12, 2005
Genetics and proteomics in sclerodermaCarol A Feghali-Bostwick
American Journal of Physiology. Lung Cellular and Molecular Physiology|April 12, 2005
IGF-I: mediator of fibrosis or carcinogenesis?Carol A Feghali-Bostwick
The American Journal of Pathology|May 10, 2008
Insulin-like growth factor-II is increased in systemic sclerosis-associated pulmonary fibrosis and contributes to the fibrotic process via Jun N-terminal kinase- and phosphatidylinositol-3 kinase-dependent pathwaysEileen Hsu, Carol A Feghali-Bostwick
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|January 7, 2014
Role of endostatin in fibroproliferative disorders.-as a candidate for anti-fibrosis therapy-Yukie Yamaguchi, Carol A Feghali-Bostwick
Frontiers in Pharmacology|June 7, 2014
Fibroblasts in fibrosis: novel roles and mediatorsRyan T Kendall, Carol A Feghali-Bostwick
The Open Rheumatology Journal|July 18, 2012
Insulin-like growth factor binding proteins-3 and -5: central mediators of fibrosis and promising new therapeutic targetsKristen L Veraldi, Carol A Feghali-Bostwick
American Journal of Respiratory and Critical Care Medicine|April 8, 2011
Autoimmunity in idiopathic pulmonary fibrosis: are circulating autoantibodies pathogenic or epiphenomena?Carol A Feghali-Bostwick, David S Wilkes
Arthritis & Rheumatology (Hoboken, N.J.)|February 28, 2014
Editorial: molecular insights into systemic sclerosis-associated interstitial lung diseaseRichard M Silver, Carol A Feghali-Bostwick
Plos One|February 20, 2014
The membrane-associated adaptor protein DOK5 is upregulated in systemic sclerosis and associated with IGFBP-5-induced fibrosisHidekata Yasuoka, Yukie Yamaguchi, Carol A Feghali-Bostwick
Critical Reviews in Eukaryotic Gene Expression|January 17, 2008
Gene expression in pulmonary fibrosisEileen Hsu, Hidekata Yasuoka, Carol A Feghali-Bostwick
Pageof 8

Showing results (1-10 of 80) with videos related to

Sort By:
Pageof 8
Current Rheumatology Reports|March 12, 2005
Genetics and proteomics in sclerodermaCarol A Feghali-Bostwick
American Journal of Physiology. Lung Cellular and Molecular Physiology|April 12, 2005
IGF-I: mediator of fibrosis or carcinogenesis?Carol A Feghali-Bostwick
The American Journal of Pathology|May 10, 2008
Insulin-like growth factor-II is increased in systemic sclerosis-associated pulmonary fibrosis and contributes to the fibrotic process via Jun N-terminal kinase- and phosphatidylinositol-3 kinase-dependent pathwaysEileen Hsu, Carol A Feghali-Bostwick
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|January 7, 2014
Role of endostatin in fibroproliferative disorders.-as a candidate for anti-fibrosis therapy-Yukie Yamaguchi, Carol A Feghali-Bostwick
Frontiers in Pharmacology|June 7, 2014
Fibroblasts in fibrosis: novel roles and mediatorsRyan T Kendall, Carol A Feghali-Bostwick
The Open Rheumatology Journal|July 18, 2012
Insulin-like growth factor binding proteins-3 and -5: central mediators of fibrosis and promising new therapeutic targetsKristen L Veraldi, Carol A Feghali-Bostwick
American Journal of Respiratory and Critical Care Medicine|April 8, 2011
Autoimmunity in idiopathic pulmonary fibrosis: are circulating autoantibodies pathogenic or epiphenomena?Carol A Feghali-Bostwick, David S Wilkes
Arthritis & Rheumatology (Hoboken, N.J.)|February 28, 2014
Editorial: molecular insights into systemic sclerosis-associated interstitial lung diseaseRichard M Silver, Carol A Feghali-Bostwick
Plos One|February 20, 2014
The membrane-associated adaptor protein DOK5 is upregulated in systemic sclerosis and associated with IGFBP-5-induced fibrosisHidekata Yasuoka, Yukie Yamaguchi, Carol A Feghali-Bostwick
Critical Reviews in Eukaryotic Gene Expression|January 17, 2008
Gene expression in pulmonary fibrosisEileen Hsu, Hidekata Yasuoka, Carol A Feghali-Bostwick
Pageof 8